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ABSTRACT OF THESIS 
EFFECT OF NICOTINE AND MUSCLE PERFORMANCE USING A  
WINGATE ANAEROBIC TEST ON COLLEGIATE FOOTBALL PLAYERS 
 
 Nicotine is a naturally occurring addictive alkaloid and in some cases, a lethal 
drug.  The long-term harmful effects of nicotine have been widely documented through 
means of publications, commercials and even billboards to stop the use of nicotine in the 
form of tobacco.  Even with the knowledge of these harmful side effects, thousands of 
athletes still use tobacco.  In this study the use of nicotinic substances was tested during 
Wingate Anaerobic Tests (WAnT) on collegiate football athletes.  These tests had three 
possible outcomes: ergogenic, ergolytic or no effect.  The subjects were 12 University of 
Wisconsin – Whitewater football players between the ages of 19 - 23.  They performed a 
series of two tests on a Monarch cycle ergometer for 30 seconds at a time on two separate 
days.  One day post-nicotine gum administration; the other day post-placebo gum 
administration.  The data received was considered significant with a p-value < .05.  This 
experiment showed nicotine’s effect on: peak anaerobic power (P = .34), anaerobic 
capacity (P = .92), and anaerobic fatigue percentage (P = .33) in the human body during a 
WAnT.  Therefore, the data received from this experiment were concluded not to be 
statistically significant. 
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CHAPTER I 
INTRODUCTION 
 
The use of nicotine is prevalent in today’s society.  Nicotine is a colorless and 
potent liquid alkaloid naturally found in all tobacco plants.  It is used in drugs such as: 
smokeless tobacco, cigarettes and cigars (Metz, Gregersen, & Malhotra 2004). There is 
much research suggesting that tobacco has many harmful long-term effects.  Several 
studies have also shown that caffeine and creatine have improved muscular performance 
in the human body during exercise (Racette 2003; Spriet 1995), whereas, little has been 
published regarding nicotine’s effect on the human body during exercise conditions.  
Landers et al. (1992) reported that there are less than 30 articles published articles on 
smokeless tobacco use.  Two-thirds of these articles concentrated on the health effects of 
smokeless tobacco.  Only one-third of these articles illustrated the physiological and 
exercise performance effects.  There is currently no published work on the effect nicotine 
has on the human body during a supramaximal exercise test such as the Wingate 
Anaerobic Test (WAnT). 
Despite the lack of publications, the question remains as to why athletes continue 
to use these damaging tobacco substances?  Landers, Crews, Boutcher, Skinner, and 
Gustafsen (1992) stated that despite the Surgeon General’s warnings to the general 
population that the use of tobacco products can be harmful and terminally fatal, many 
athletes believe that smokeless tobacco enhances athletic performance.  This ergogenic 
tobacco theory stems from the belief that performance enhancement comes from 
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prevention of dry mouths, improvements in reaction time and concentration abilities, and 
euphoric calming effects for pre-participation rituals.  The effects of nicotine use in the 
human body vary.  However, in high doses it can produce detrimental effects.  This 
experiment was designed to show the effects of nicotine on collegiate football players 
during a WAnT. 
Effects at Rest and Exercise 
The effects of nicotine in the body vary during resting and exercising conditions.  
Studies by Symons and Stebbins (1996) showed that nicotine infusions during resting 
states caused hypertension, decreased cardiac output, increased blood pressure and 
decreased heart rate.  Also, it increased blood levels of epinephrine and norepinephrine, 
decreased urine output, increased satiety, and increased systemic and regional vascular 
resistance (e.g., left ventricle, kidneys, splanchnic organs).  During exercise nicotine 
caused small elevations in myocardial oxygen demand, arterial pressure, systemic and 
regional vascular resistance (e.g., proximal colon and pancreas).  It is believed that the 
vasodilators in the heart trumped the effects of nicotine known during resting conditions.  
The findings of this study suggested that the inhibiting effects of nicotine at rest are 
minimized during exercise. 
Tobacco and Autonomic Effects 
The study by Narkiewicz, van de Borne, Hausberg, Cooley, Winniford, Davison, 
and Somers (1998) showed the effects of smoking increased norepinephrine and 
increased blood pressure.  The results of an increase in blood pressure produce arterial 
baroreflexes that exerted a protective effect by inhibiting sympathetic activation and 
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tachycardia that resulted from smoking.  (It is unknown if this was the result of nicotine 
or other chemicals found in cigarette smoke.)  The drug Nitroprusside was administered 
to decrease the blood pressure and block the arterial baroreflexors.  The result of this test 
proved that smoking had a powerful sympathetic excitatory effect.  This finding was 
comparable to Wolk, Shamsuzzaman, Svatikova, Huyber, Narkiewicz, and Somers 
(2005). They reported that muscle sympathetic nerve activity (MSNA) and 
norepinepherine concentrations had no change using smokeless tobacco.  However, it did 
show an increase in heart rate, blood pressure and epinephrine by 50% of their subjects. 
Despite a small population (n=16), smokeless tobacco confirmed that it is a powerful 
autonomic stimulus. 
Van Duser and Raven (1992) suggested smokeless tobacco had strong 
sympathetic nervous system stimulation as well.  Their findings concluded smokeless 
tobacco decreased endurance performance by means of an increase in heart rate and 
plasma lactate concentrations.  When plasma lactate concentrations were high it 
suggested that there was a demand for glycolytic energy production, because of reduced 
muscle blood flow in the smokeless tobacco subjects.  Therefore if lactate levels rose in 
cardiac muscle it could have detrimental effects on individuals at risk from congenital 
heart disease. 
Nicotine and Psychomotor Performance 
Landers et al. (1992) showed ergogenic effects in regards to vigilance, rapid 
information processing, state dependent learning and retention of paired associates.  Their 
report stated that nicotine use had no effect on psychomotor tasks, but did have an 
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enhancing effect on cognitively demanding stressor tests. Also noted were elevations in 
heart rate and blood pressure in smokeless tobacco users compared to non-users.  Escher, 
Tucker, Lundin, and Grabiner (1998) attempted to demonstrate the significance between 
smokeless tobacco, reaction time and strength in athletes.  The subjects were tested on a 
KinCom dynamometer for reaction time, maximum voluntary force and maximum rate of 
force generation of the knee extensors.  The results showed that tobacco did not have any 
effect on reaction time, but had a significant effect on decreasing strength.  The 
experimenters were unsure if the effect was a substance in the smokeless tobacco 
producing an ergolytic effect, or if tobacco withdrawal stimulates an ergogenic effect.  
Hindmarch, Kerr, and Sherwood (1990) provided a more extensive investigation using 
nicotine gum on a variety of psychometric tests.  These tests included: choice reaction 
time, memory scanning, tracking and flicker fusion threshold.  The results proved that 
additional nicotine gum provided smokers with an ergolytic effect in speed and accuracy 
of motor activity.  In contrast, the non-smokers demonstrated no significant findings that 
skewed the results. 
Tobacco and Cardiovascular Effects 
The study by Bolinger, Noren, Wahren, and De Faire (1997) determined the effect 
of tobacco use during a cardiovascular and pulmonary functioning test in middle-aged 
men.  No significant differences were found between middle-aged smokeless tobacco 
users and non-users.  However, significant data supported that smokers showed lower 
maximal working capacity and oxygen uptake compared to non-users.  This study 
hypothesized that recurring exposure to nicotine directly influences the autonomic 
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nervous system and thus results in an increasing risk of cardiac problems related with the 
heart.  Overall this study showed no significant difference in performance associated 
from the effects of nicotine.  However, it should be noted that the subjects in this study 
were firemen and other active individuals.  Siegel, Benowitz, Ernster, Grady, and Hauck 
(1992) attempted to perform a similar test.  This study’s findings indicated agreement 
with Bolinger et al. (1997) that there was minimal data concerning long-term 
cardiovascular effects in the test subjects, who were professional baseball players and 
exercised regularly.  The moderate to high physical fitness of these individuals may have 
minimized the effectiveness of tobacco on the cardiovascular system. 
Physiology 
There are many philosophies that attempt to explain the nicotine effects in the 
body.  Landers et al. (1992) declared the multiple physiological changes linked with the 
use of smokeless tobacco: “vasoconstriction; decreased peripheral circulation; increased 
secretion of antidiuretic hormone and catecholamines; and increased levels of blood 
lipids, plasma glucose, glucagon, insulin, and cortisol.”  Some theories were conclusive, 
but others were inconclusive or even contradicted one another.  That is why it is 
imperative to look at the physiology of the human body. 
In the human body, nerve stimulation produces a strength stimulus.  The 
peripheral nerves tell the central nervous system how much stimulus is needed to produce 
the intended response.  To produce these responses neurotransmitters are necessary to aid 
in the speed and strength of the stimuli.  Neurotransmitters travel in the electrical form of 
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action potentials from dendrites to cell bodies to axons or muscle fibers.  Every axon has 
synapses with chemical ion channels that directly affect these action potentials. 
Acetylcholine (ACh) is the main neurotransmitter that affects a muscle response 
(Shier, Butler, and Lewis 2003).  When ACh binds to its receptors, it directly or 
indirectly causes an opening in ion channels.  In most somatic cases this produces effects 
of depolarization called excitatory postsynaptic potential (EPSP).  In autonomic cases this 
will produce a hyperpolarization called an inhibitory postsynaptic potential (IPSP).  
Whether ACh is excitatory or inhibitory is dependant on the muscle fiber type or the 
organ involved (Fox 1999).  In a synapse, ACh receptors can be stimulated by the toxins 
nicotine and muscarine.  Nicotine, which is found in tobacco, stimulates receptors called 
nicotinic ACh receptors (nAChRs).  These nAChRs produce an excitatory response of 
ACh on skeletal muscle cells.  Muscarine (a drug found in poisonous mushrooms) 
stimulates muscarinic receptors that produce an inhibitory response on muscle cells.  The 
effect of one of these drugs will produce their respective ACh receptors to open ion 
channels to carry out its response (McArdle, Katch, and Katch 2001). 
In the case of this experiment, nicotine allows the nACh receptors to bind to the 
neurotransmitter ligand and allow an influx of Na+.  This influx causes a depolarization in 
the postsynaptic membrane to act as an EPSP.  EPSP’s stimulate the postsynaptic cell to 
produce action potentials.  The resting membrane potential depolarizes from –70 
millivolts (Na+ into cell) to +30 millivolts and back again (K+ out of cell) when 
repolarization takes place milliseconds later.  This action potential produces a “domino 
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effect” for more action potentials to take place down the axon until the intended response 
is complete (Pranzatelli 1999). 
The amplitude of action potentials is “all or none.”  This means that when 
depolarization is below a stimulus threshold the ion channels remain closed and an action 
potential will not occur.  However, when it does reach threshold an action potential will 
reach the maximum amplitude.  If one stimulus is greater than another, there will be a 
need for a greater frequency of action potentials to complete the greater stimulus 
response.  Stimulus strength in the nervous system is frequency modulated because action 
potentials are “all or none” (Pranzatelli 1999).  Li and Eisenach (2002) declared that 
nACHRs induce norepinepherine release.  This results in a “feed-forward mechanism,” 
because norepinepherine release stimulates more ACh, and then in turn arouses more 
norepinepherine release. 
Wingate Anaerobic Test 
There are many measurements and tests evaluating energy sources in the human 
body.  In this thesis anaerobic glycolysis was the primary energy source measured by the 
WAnT.  Ayalon, Inbar, and Bar-Or first developed the WAnT in 1974 at the Department 
of Research and Sport Medicine of the Wingate Institute for Physical Education and 
Sport in Israel (Gullstrand and Larsson 1999).  The WAnT may be performed on any 
braked bicycle ergometer, but the Monark bicycle ergometer is widely accepted as the 
ergometer of choice.  The WAnT can be performed to measure muscular performance in 
both the upper and lower extremities. 
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Muscular performance is calculated anaerobically by peak power, mean power 
and percent fatigue.  The WAnT is a supramaximal exercise for 30 seconds against a pre–
determined force load usually 7.5% of body weight in kilograms. This means that the 
subjects do not pace themselves and perform at 100% of their maximal effort.  Every five 
seconds the pedal rate is measured against the force load, giving the data for the 
experiment.  Peak power is measured in Watts as the highest interval of five seconds for 
the duration of the test.  Mean power is the average of all intervals throughout the full 30 
seconds.  Percent fatigue is the rate of fatigue calculated from the difference of peak 
power compared to the lowest power output or end power.  Gullstrand and Larsson 
(1999) reported eight investigations showing a mean reliability of r=0.94+/-3SD.  This is 
in agreement with studies by Bar-Or (1987).  Therefore, the WAnT is proven to be a 
reliable test.  
Assumptions 
This study made the following assumptions: 
1. The nicotine levels in the nicotine chewing gum were high enough to affect the 
EPSP’s in a human body. 
2. The conditions of the experiment were parallel between the two test days. 
3. The test subjects were honest and followed the protocol before the experiment.  
4. The WAnT was a valid and reliable anaerobic test. 
Purpose of the Study 
Football is a game of explosive activity and muscular strength.  A normal play 
usually lasts only a few seconds.  These short durations of play stress the importance of 
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anaerobic activity, or fast twitch muscle performance.  A WAnT is a good test for 
football athletes because it is consists of all explosive actions and fast twitch muscular 
activity.  The WAnT also parallels football because they both last short durations of time. 
Severson, Klein, Lichtenstein, Kaufman, and Orleans (2005) declared that during 
the mid-1980’s and the early 1990’s the use of smokeless tobacco among professional 
baseball players was about double the percentage of the entire population.  It is not only 
baseball players that use smokeless tobacco.  Lombardo (1986) stated that one-third of 
Texas varsity football and baseball players used nicotinic substances in the form of 
smokeless tobacco. 
When will athletes realize the harmful side effects from this fatal habit?  Critchley 
and Unal (2003) reported that there will be up to 1,000 or more nicotine related deaths in 
the U.S. every year due to oral cancer.  This mortality rate is nothing compared to India 
which sadly boasts up to 10,000 or more oral cancer related deaths accredited to 
smokeless tobacco use alone.  Since athletes still use tobacco substances today, we tested 
the effects of nicotine in the human body.  There is minimal research concerning the 
effects of nicotine during exercise.  All research was inconclusive based on the variety of 
results showing ergogenic, ergolytic and no significant statistical difference.  Therefore 
this experiment illustrated the effects of nicotine on anaerobic exercise during a WAnT. 
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CHAPER II 
METHODOLOGY 
 
Subjects 
Twelve University of Wisconsin-Whitewater intercollegiate football players were 
tested usining a WAnT on two separate days (N=12).  All test subjects were male and 
Caucasian.  One day consisted of administering nicotine gum and the other day a placebo 
was administered.  Each subject was given a one week period of recovery between tests.   
Research Design and Procedure 
 This was a single-blind experiment (test-retest).  Therefore, only the researchers 
knew which gum was administered for each day.  The statistical analysis was performed 
using a paired student’s t-test.  Testing was performed on Monark bicycle ergometers 
(Monark 834E).  The procedures required a subject, a timer and two counters for each 
test.  Each test subject wore a t-shirt, athletic shorts, and athletic shoes.  The subject 
randomly was administered a piece of chewing gum by the researcher.  The subject 
chewed the piece of gum for 30 minutes to allow optimal peak time for the possibility of 
4 mg nicotine to enter the bloodstream.  This is in agreement with clinical studies 
performed by Van Duser and Raven (1992).  During the time of chewing the gum the test 
subject had his weight taken and subsequently the brake force set up on the Monark cycle 
ergometer. 
The seat height was adjusted allowing a slight bend in the knee when the pedals 
were at the bottom of the revolution.  Then the subject had a two minute warm-up cycling 
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with no resistance at a moderate pace.  The force was then applied by dropping the 
weight holder.  The timer began counting with a stop watch for 30 seconds and called out 
time intervals every five seconds.  As the timer counted the subject was encouraged to 
keep pedaling as hard as he could by the researcher, timers and counters for the duration 
of the experiment.  One counter counted pedal revolutions during the first, third and fifth 
time intervals.  The other counter counted pedal revolutions during the second, fourth and 
sixth time intervals.  After the 30 seconds were up the resistance was removed from the 
Monark cycle ergometer and the subject cooled down until he was comfortable with 
stopping.  The data was used to calculate peak muscle power, average muscle power and 
rate of fatigue.  One week later, the subject reproduced this experiment using the other 
piece of nicotine or placebo gum that was not administered during the first test. 
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CHAPTER IV 
RESULTS 
 
 The purpose of this study was to determine if nicotine had a positive, negative, or 
no effect on muscle performance in the human body during a WAnT.  The literature 
review showed that previous research was inconclusive.  The results of this study showed 
the effects on non-tobacco using collegiate football players during a WAnT.  The ages, 
height, weight and brake weight are shown in Table 1.  Brake weight was the prescribed 
force used as resistance for the WAnT calculated by 7.5% multiplied by the body weight 
(kg) of the test subjects and rounded to the nearest 0.5 kg.  This formula was in 
agreement with the experiment done by O’ Kroy (2000). 
 
Test Subjects (N=12) Mean SD Range 
Age 20.75 1.356801 19-23 
Height (in) 71.22917 2.489657 66-75.5 
Weight (kg) 92.54167 12.33247 74.5-105.5 
Brake Weight (kg) 7.083333 0.900337 6-9 
 
Table 1: Demographics of the participants. 
 
 Table 1 reports the demographics of the 12 test participants.  There were slight 
differences in the ages and brake weights of the subjects, but there were significant 
differences in the heights and weights of the subjects. 
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Figure 5.1: Results for peak anaerobic power.  
 
 Figure 5.1 presents the data collected from all twelve subjects on peak anaerobic 
muscle power comparing the effects of nicotine verses a placebo.  Fifty percent of the 
Subjects (6 of 12) showed an increase in peak anaerobic power during the nicotine trial.  
Twenty-five percent of the subjects (3 of 12) had no difference in peak anaerobic power 
output.  Lastly, 25% of the subjects (3 of 12) showed a decrease in muscle power during 
the nicotine gum experiment in comparison with the placebo gum. 
 Table 2 reports a wide variety of peak anaerobic power values obtained from a 
paired student’s t – test.  The values showed that the mean scores were higher by 47 
Watts in the nicotine gum trials.  Standard deviation values were also more prominent in 
the nicotine gum with a greater difference of 14 Watts.  The p-value was greater than .05 
(P = .34).  Therefore, one cannot claim this as statistically significant data. 
Figure 5.2 presents the data collected from all twelve subjects on anaerobic 
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Nicotine Gum Placebo Gum 
Mean 937 Mean 890 
95% CI 825.3 - 1049 95% CI 786.9 - 993.1 
SD 176 SD 162 
Median 882 Median 888 
 
t-score 1 DF 11 P-value 0.34 
 
Table 2: Comparison of peak anaerobic power values for nicotine and placebo trials. 
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Figure 5.2:  Results for anaerobic capacity. 
 
capacity or mean anaerobic muscle power output.  The effects again show the values of 
nicotine in comparison with a placebo.  Fifty percent of the subjects (6 of 12) showed an 
increase in anaerobic capacity during the nicotine trial.   In contrast, 50% of the football 
players (6 of 12) showed a decrease in anaerobic capacity during the nicotine trial. 
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Nicotine Gum Placebo Gum 
Mean 696 Mean 694 
95% CI 626 – 765.7 95% CI 617 – 771 
SD 110 SD 121 
Median 679 Median 686 
 
t-score 0.1 DF 11 P-value 0.92 
 
Table 3: Comparison of anaerobic capacity values for nicotine and placebo trials. 
 
 As seen in Table 3, the values for anaerobic capacity were similar.  The mean 
scores were almost identical with nicotine scores edging placebo scores by a difference of 
2 Watts.  The nicotine standard deviation scores were 11 Watts smaller than the placebo.  
Because the resulting p-value of 0.92 was far from the 0.05 level of significance, this data 
was not statistically significant. 
 Figure 5.3 presents the data collected from all twelve subjects on anaerobic 
fatigue.  This comparison between nicotine gum and placebo gum was based on the 
percentage of decline in performance from the highest to lowest five second intervals 
throughout the 30 second experiment.  A lower percentage rate for the experiment 
indicated a better effect of maintaining performance; a higher percentage rate indicated 
decrease in muscle performance.  Fifty percent of the subjects (6 of 12) showed a greater 
percentage loss in the nicotine gum trial.  Forty-two percent of the subjects (5 of 12) 
showed a lower percentage from nicotine gum.  Finally, eight percent of the subjects (1 
of 12) showed no difference from both trials of anaerobic fatigue. 
 As seen in Table 4, the values are comparable.  The subjects had a larger drop off 
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Figure 5.3: Graph results for percentage of anaerobic fatigue. 
 
in anaerobic fatigue from highest peak interval to lowest end interval when the percent 
score was greater.  Consequently, mean scores were higher in nicotine gum by a 
difference of 4%.  Nicotine gum had a lower standard deviation by 2%.  The resulting p – 
value was 0.33. 
 
Nicotine Gum Placebo Gum 
Mean 47% Mean 43% 
95% CI 42% – 53% 95% CI 35% – 50% 
SD 9% SD 11% 
Median 48% Median 40% 
 
t-score 1.01 DF 11 P-value 0.33 
 
Table 4:  Comparison of percentage of anaerobic fatigue in nicotine and placebo trials. 
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CHAPTER V 
DISCUSSION 
 
 In a world where athletes are trying to gain an edge on the competition, it is 
apparent that athletes continue supplemental use of ergogenic aids.  Ahrendt (2001) 
reported that 76% of college athletes currently used or had tried some form of 
supplement.  In a survey performed in 1996, 50% of the general population had 
experimented with some form of supplement.  It was also revealed that 100% of body 
builders used supplements.  This data gives evidence that an athlete’s quest for obtaining 
an edge on competition is limitless.   
 Despite the warnings and potential side effects of some supplementals, athletes 
continue to use ergogenic aids.  When will this madness end?  What can be done to 
prevent athletes from potentially harming their bodies?  Presently we see Major League 
Baseball beginning to put limitations on some of these substances, as well as 
implementing penalties for the use of these substances.  San Francisco Chronicle 
reporters Mark Fainaru-Wada and Lance Williams wrote the book Game of Shadows 
(2006) to try and expose professional athletes and their involvement in using some of 
these illegal ergogenic aids.  Most notably they attacked public figures Barry Bonds, 
Mark McGwire, Jason Giambi and Marion Jones with allegations of their illegal drug 
use.  These public figures were portrayed as role models by the media.  Unfortunately, 
their actions in these allegations send a horrifying message to aspiring athletes: 
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tomorrow.: that one must use ergogenic aids if one aspires to become an elite 
professional athlete. 
 Some athletes perceive nicotine as an ergogenic aid.  Lombardo (1986) stated that 
the occurrence of nicotine use in sports was designed to achieve stimulation, relaxation, 
and weight control.  Landers et al. (1992) described that athletes also believe that 
smokeless tobacco enhances performance by preventing dry mouths, improving 
concentration, improving reaction time and providing an arousal effect.  If nicotine does 
provide athletes with these effects, should there be a ban on these nicotinic substances to 
provide a level playing field? 
 The primary purpose of this experiment was to analyze statistical significance of 
the effects nicotine had on muscular performance in collegiate football players.  Muscular 
performance was identified and measured in this experiment by peak anaerobic power, 
anaerobic capacity, and percentage of anaerobic fatigue.  A p-value of less than 0.05 was 
considered statistically significant.  However, in these findings all three categories 
measured were considered not statistically significant due to p-values greater than 0.05.  
This data is in agreement with research done by Bolinger et. al. (1997), Hindmarch et. al. 
(1990), Landers et. al. (1992), and Siegel (1992).  These findings are in contrast with 
research done by Escher et. al. (1998) who believed that smokeless tobacco decreased 
muscular strength.  Though conflicting evidence is apparent one must look at the 
limitations of this experiment.  Only 12 male collegiate football players from the 
University of Wisconsin – Whitewater were tested.  The subjects may have failed to 
follow the research protocol properly.  They also may have had physical injuries that 
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limited their maximal abilities.  The subjects may have performed better on the second 
day due to a learning effect.  Finally, there may have been human error from the manual 
pedal revolution counting by the researchers throughout the test. 
In the future it is recommended to further investigate the effects of nicotine and 
muscular performance.  Recommendations for future research on nicotine and muscle 
performance include: 
1. Increasing the sample size.  This will ensure a larger validity of the experiment. 
2. Using cycle ergometers with computerized systemns that automatically count 
pedal rate and determine the results to prevent human error. 
3. Using a variety of subjects from different sports, races and genders. 
4. Comparing the effects of nicotine users and non-users. 
5. Improve validity and other factors that may influence an effect using nicotine. 
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